Short Communication
The In Vitro Function of Lymphocytes from 25 Cancer Patients Receiving Four to Seven Consecutive Days of Recombinant IL-2
Therapy of Disseminated NK-Resistant Tumor by the Synergistic Effects of Recombinant Interleukin-2 and Tumor Necrosis Factor
Differential In Vitro Effects of Recombinant α-Interferon and Recombinant γ-Interferon Alone or in Combination on the Expression of Melanoma-Associated Surface Antigens
Development and Characterization of Two Neutralizing Monoclonal Antibodies to Human Interleukin-1α
Effects of Heparin on In Vitro Immune Parameters
Soluble Glucan and Lymphokine-Activated Killer (LAK) Cells in the Therapy of Experimental Hepatic Metastases
Modulation by RU 41740 of Oxidative Metabolism and Migration of Rat Polymorphonuclear Leukocytes Collected After Induction of Immune and Nonimmune Inflammations
Human Lymphocyte and Monocyte Lysis of Tumor Cells Mediated by a Mouse/Human IgG1 Chimeric Monoclonal Antibody
Monoclonal Antibody to the Streptococcal Preparation OK-432